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ABSTRACT: Enzymatic stereodivergent synthesis to access all possible product stereoisomers bearing multiple stereocenters is 
relatively undeveloped, although enzymes are being increasingly used in both academic and industrial areas. When two 
stereocenters and thus four stereoisomeric products are involved, obtaining stereodivergent enzyme mutants for individually 
accessing all four stereoisomers would be ideal. Although significant success has been achieved in directed evolution of enzymes in 
general, stereodivergent engineering of one enzyme into four highly stereocomplementary variants for obtaining the full 
complement of stereoisomers bearing multiple stereocenters remains a challenge. Using Candida antarctica lipase B (CALB) as a 
model, we report the protein engineering of this enzyme into four highly stereocomplementary variants needed for obtaining all 
four stereoisomers in transesterification reactions between racemic acids and racemic alcohols in organic solvents. By generating 
and screening less than 25 variants each isomer, we achieved >90% selectivity for all of the four possible stereoisomers in the 
model reaction. This difficult feat was accomplished by developing a strategy dubbed “focused rational iterative site-specific 
mutagenesis” (FRISM) at sites lining the enzyme’s binding pocket. The accumulation of single mutations by iterative site-specific 
mutagenesis using a restricted set of rationally chosen amino acids allows the formation of ultra-small mutant libraries requiring 
minimal screening for stereoselectivity. The crystal structure of all stereodivergent CALB variants, flanked by MD simulations, 
uncovered the source of selectivity. 
INTRODUCTION
Different enantiomers of a biologically active molecule 
generally have different physiological properties, such as 
different degree or different type of biological activities, or 
even opposite bioactivity or toxic side effects.1 One of the 
most representative examples is thalidomide, which has been 
cited many times in discussions of this kind.1,2 The 
relationship between the chirality of molecules and their 
bioactivity becomes substantially more complex when 
compounds contain multiple stereocenters. For example, (2R, 
3R)-paclobutrazol is a fungicide, while (2S, 3S)- paclobutrazol 
is a plant growth regulator.3 The (S, S)-form of ethambutol is a 
front-line anti-tuberculosis drug, while the (R,R)-enantiomer is 
completely inactive against mycobacterium tuberculosis, and 
the (R, S)-diastereomer is 16 times less effective.4 Thus, it is 
necessary to have easy access to all theoretically possible 
stereoisomers of a drug candidate in order to evaluate their 
bioactivity carefully. Despite remarkable progress in the field 
of asymmetric synthesis over the past few decades,5 complete 
control of multiple stereogenic centers for obtaining all 
possible stereoisomers in catalyst-controlled reactions remains 
a challenge.
Asymmetric transformations such as desymmetrization of 
meso-epoxides by Jacobsen-catalysts allow access to both of 
the expected enantiomers, but not to the respective 
diastereomers.6 Some well-designed man-made catalysts for 
stereodivergent synthesis methods have emerged which allow 
access to some and in rare cases even all stereoisomeric 
products with multiple stereocenters from the same set of 
precursors. For example, Carreira and coworkers described the 
fully stereodivergent synthesis of γ,δ-unsaturated aldehydes 
bearing two vicinal quaternary/tertiary stereogenic centers by 
an ingenious dual catalytic procedure based on a chiral Ir-
catalyst and a chiral amine co-catalyst for accessing all four 
stereoisomers.7 In a different and likewise impressive 
approach, Buchwald and co-workers recently demonstrated 
the synthesis of all stereoisomers of a set of 1,3-amino 
alcohols bearing up to three contiguous stereocenters through 
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sequential, copper-hydride-catalyzed hydrosilylation and 
hydroamination of readily available enals and enones.8 
Diverse reviews have appeared describing asymmetric 
catalysis in which more than one stereocenter is involved.9
Enzymatic stereodivergent synthesis for accessing all 
possible stereoisomers bearing multiple stereocenters is a 
relatively undeveloped domain, although biocatalysts are 
being increasingly used in both academic and industrial 
laboratories.10 For example, hydrolytic desymmetrization of 
meso-epoxides catalyzed by epoxide hydrolases allows entry 
into the two enantiomeric products, but generally not to the 
diastereomers.11 The general problem may be due to the 
exquisite selectivity of enzymes, which usually causes limited 
substrate acceptance and access to only one of the possible 
stereoisomeric products. An alternative method utilizes 
tandem reactions, in which several enzymes sequentially 
control different stereocenters of products.12-13 For example, 
we recently reported the combination of P450-BM3 mutants 
and appropriate alcohol dehydrogenases as catalysts in 4-step 
cascade reactions starting from cyclohexane leading optionally 
to either (R,R)-, (S,S)-, or (R,S)-cyclohexane-1,2-diols.12 This 
was achieved by applying directed evolution using the 
combinatorial active-site saturation test (CAST) and iterative 
saturation mutagenesis (ISM) at residues lining the binding 
pocket.14 However, developing a simple and rapid method 
based on a single enzyme for the complete control of absolute 
and relative configuration of products having multiple 
stereogenic centers and with selective formation of all 
theoretically possible stereoisomers represents a synthetic 
challenge in asymmetric biocatalysis. 
Whereas stereocomplementary enzymes with formation of 
products having single stereocenters exist in nature15 or can 
evolved by directed evolution,14,16 it is unlikely that those with 
divergent stereoselectivity leading to four different products 
with two stereogenic centers on an optional basis will be found 
without turning to mutagenesis.10 In principle, several different 
reaction types can be considered in order to obtain products 
having two newly created stereogenic centers, mediated either 
by enzymes or man-made catalysts. For example, in P450-
BM3 catalyzed desymmetrization of appropriate achiral 
compounds (or meso-compounds) such as methylcyclohexane 
with formation of 1-hydroxy-2-methylcyclohexane, only one 
of the four stereoisomers proved to be accessible by directed 
evolution.17 A different reaction type is cyclopropanation of 
styrene, e.g., catalyzed by mutant Fe-heme proteins, in which 
two out of the four possible stereoisomers could be produced 
with reasonable selectivity.18 It is worth noting that for some 
substrates, all four possible stereoisomers in the 
cyclopropanation were also obtained by using three different 
enzymes.18a To the best of our knowledge, so far few 
precedents are available on the directed evolution of an 
enzyme for a stereodivergent reaction in which all four 
possible stereoisomeric products were accessed. Hilvert and 
coworkers reported the directed evolution of an artificial retro-
aldolase which was engineered for promiscuous Michael 
reactions leading optionally to four stereocomplementary 
products with 80-85% selectivities.19 In this interesting 
process, CH-acidic Michael donors such as cyano acetic acid 
ethyl ester undergo rapid racemization prior to addition to 
prochiral α, ß-unsaturated ketones.
With these challenges in mind, we considered a very 
different reaction class and enzyme type. It concerns the 
stereodivergent protein engineering of a single wildtype (WT) 
lipase10 into four highly stereocomplementary variants for 
transesterification reactions in organic solvents. Candida 
antarctica lipase B (CALB) was chosen as the model enzyme 
to be evolved, one of the most extensively used biocatalysts in 
both industrial and academic laboratories.10,20 It has two 
binding pockets at the active site for the acid (acyl) and 
alcohol parts of ester substrates, respectively.20 Based on 
previous protein engineering studies and structural knowledge 
of the two selectivity pockets of CALB,20b,21,22 we envisioned 
that the respective selectivities determined by the acyl or 
alcohol-binding pockets of CALB could be combined to form 
four highly stereocomplementary variants that exert control 
over the transesterification reactions of racemic ester rac-1a 
and alcohol rac-2a in organic solvents (Scheme 1). This 
means that we aimed to perform the reactions with 50% 
conversion in a kind of kinetic resolution (KR).10,23
Scheme 1. Stereodivergent Transacylation between 2-
Phenylpropionic Acid p-Nitrophenyl Ester (rac-1a) and 1-
Phenylethanol (rac-2a) Catalyzed by CALB Mutants.
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Although non-aqueous reaction conditions increase the 
difficulty of direction evolution, which has been rarely 
implemented,24a we succeeded in engineering the selectivities 
(exceeding 90%) for each of the four possible stereoisomers in 
the model reaction (Scheme 1) by screening less than 100 
transformants. The achievement is based on a new protein 
engineering strategy which we call “focused rational iterative 
site-specific mutagenesis” (FRISM). As will be seen, it is a 
logical fusion of rational design and directed evolution.
RESULTS AND DISSCUSSION
Creation of Ultra-Small Focused CALB Mutant 
Libraries for Screening in an Organic Solvent. In contrast 
to lipase-catalyzed hydrolysis in aqueous medium, 
transacylation in an organic solvent can be used more widely, 
because of some specific advantages of nonaqueous 
enzymology, including the high solubility of organic 
substrates in organic solvents and the solvent-dependency of 
enzyme properties.25 A special area of enzyme catalysis in 
non-aqueous media is dynamic kinetic resolution (DKR) of 
sec-alcohols or sec-amines.26 To date, almost all protein 
engineering examples of lipases dealt with the hydrolysis of 
esters in an aqueous medium using high-throughput screening. 
An exception is the directed evolution of Candida antarctica 
lipase A (CALA) for enantioselective transacylation of sec-
alcohols in organic solvents.24a It should be noted that the best 
mutants obtained from hydrolysis reactions may not perform 
equally well for transacylation in organic solvents, since non-
negligible solvent dependency for enzyme selectivity has been 
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observed,27 and even reversed enantioselectivity may occur 
when changing from water to organic solvents.27b-c 
Since the solvent has a great effect on lipase-catalyzed KR, 
we first tested the activity and enantioselectivity of WT CALB 
(immobilized on acrylic resin) toward the model reaction in 8 
different organic solvents at 37 °C. Unfortunately, WT CALB 
showed poor diastereoselectivity in all of the tested solvents, a 
mixture of (2S, 1’R)-3a and (2R, 1’R)-3a being the main 
products (Table S1). Considering the relatively high activity 
observed in isopropyl ether (IPE), this solvent was chosen for 
subsequent mutagenesis and screening steps. 
The difficulty for transacylation-based screening in organic 
solvents lies in the laborious purification, lyophilization or 
immobilization of each mutant in a large or medium-sized 
library. Although a method for microtiter-plate screening in 
organic solvents has been reported, it was used for lyophilized 
enzymes and not tested for enantioselectivity.28 A seminal 
method for screening in organic solvents using nickel-coated 
96-well microtiter plates was reported by Bäckvall et al.24a 
Alternatively, in order to reduce the costs, time and labor in 
the screening step, we set out to devise a mutagenesis method 
that allows the rapid creation of ultra-small focused libraries 
of high-quality comprising only a few dozen mutants, and 
requiring minimal screening. 
In order to reach this goal, we developed a strategy, in 
analogy to ISM,14 called “focused rational iterative site-
specific mutagenesis” (FRISM) (Fig. 1). Instead of generating 
focused saturation mutagenesis libraries at sites lining the 
binding pocket in an iterative manner using highly reduced 
amino acid alphabets as building blocks as in CAST/ISM14 or 
in a manner based on the use saturation mutagenesis 
simultaneously at several residues employing one or two 
chosen amino acids as building blocks at each position24a-b, 
FRISM calls for rational decisions on the choice of a highly 
limited set of amino acids to be introduced at the chosen 
CAST sites by site-specific mutagenesis in an iterative 
manner. Saturation mutagenesis is not involved in this 
approach. Notice that each new collection of mutants in a 
FRISM step constitutes a mini-library, radically smaller in size 
than the focused libraries in traditional saturation 
mutagenesis.14 Depending upon the particular enzyme and the 
catalytic parameter to be evolved,24 different structure-based 
choices need to be made. In the present study, we focused 
primarily on the steric properties of the amino acids when 
applying site-specific mutagenesis, and made rational 
decisions in order to reshape selected domains in the CALB 
binding pocket iteratively for accepting sterically demanding 
substrates. 
Firstly, the crystal structure of CALB (PDB ID: 1TCA)20b 
was viewed closely for choosing appropriate mutation 
residues. The active site of CALB is characterized by the 
catalytic triad Asp187-His224-Ser105, an oxyanion hole, and 
a binding pocket composed of two domains, one for the acyl-
moiety of the ester and another for the alcohol-part, 
respectively. It was logical to assume that the amino acid 
residues around the active site of CAL-B are the most 
influential ones for improving stereoselectivity and activity, 
since many successful examples for manipulating these 
enzyme parameters genetically are based on CAST.14 
Following a thorough analysis of the structure of the CALB 
active site into which we docked substrate 1a, seven mutation 
sites were selected for generating the respective focused mini-
library (Fig. 1C). 
Figure 1. Representation of “focused rational iterative site-
specific mutagenesis” (FRISM) and the X-ray structure of 
WT CALB.20b (A) Rationally identifying single amino acid 
(AA) residues for site specific mutagenesis. (B) FRISM based 
on 2 or 3 mutagenesis single sites, involving 2 or 6 upward 
pathways, respectively. (C) X-ray structure of WT CALB and 
amino acid residues included in the focused library. The 
residues of the catalytic triad Asp187-His224-Ser105 are 
shown in pink, and mutagenesis sites are shown in green/red 
stick illustrations. Alanine (A), leucine (L), and phenylalanine 
(F), regarded as small, medium and large amino acids, 
respectively. A+, L+, and F+, regarded as amino acids with 
similar steric properties used in the formation of extension 
libraries, including G, V/C/I/M and Y/W, respectively.
We then proceeded with FRISM in the following manner. A 
group of amino acids with different steric properties was 
chosen to replace the amino acids individually at the selected 
mutation sites: Alanine (A) or glycine (G), leucine(L), and 
phenylalanine(F) were regarded as small, medium and large 
amino acids, respectively, for modifying the space available in 
the two CALB binding pockets. Then, the obtained mutants 
were tested in the model reaction (Scheme 1) to identify the 
best key sites (“hotspots”) for manipulating stereoselectivity. 
This procedure is related to, but not identical to a strategy 
exploiting exploratory NNK-based SM at single residues 
lining the binding pocket, which enables rational decisions 
regarding the choice of reduced amino acid alphabets for 
further CAST/ISM at multi-residue randomization sites.14 
Since in the present case these simple exploratory experiments 
revealed some hits, a few additional mutations with similarly 
sized amino acids (A+, L+ or F+) were then introduced 
individually at the key sites as an “extension-library” and 
screened for enhanced enantioselectivity. A+, L+ and F+ 
included G, V/C/I/M and Y/W, respectively.
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Figure 2. Focused rational iterative site-specific mutagenesis (FRISM) of CALB to obtain four enantioselective variants (A-D) as 
catalysts in the transacylation reactions between 2-phenylpropionic acid p-nitrophenyl ester (rac-1a) and 1-phenylethanol (rac-2a) 
providing four different enantio- and diastereomeric products 3a with diastereoselectivies ranging from 91:9 to 95:5 dr and 
enantioselectivies >99:1 er. Selectivity factors E are shown separately in Table 1. Abbreviations used: 1st -4th G: 1st to 4th generation 
of mutations; Sele.: selectivity, the percentage of the specific enantiomer in four different enantiomer of product 3a. Conversion 
data are shown in parentheses after the selectivity data of variants. HPLC conditions: OJ-H, hexane: isopropanol =80:20. The 
selectivity or percentage of four different enantiomers of product 3a in the model reaction catalyzed by various CALB mutants 
generated in the directed evolution process are listed in Table S2.
In the alcohol binding pocket, residue W104 is known to be 
an important site for manipulating the stereoselectivity of 
CALB toward racemic secondary alcohols.21a WT CALB 
displays excellent (R)-selectivity for many sec-alcohols, while 
some mutants such as W104A, first reported by Hult and 
coworkers,21a reverses enantioselectivity to (S). Therefore, the 
decision was made to explore directed evolution along two 
different routes.
In the first route, we kept W104 unchanged to maintain (R)-
selectivity of CALB toward the alcohol part of the substrate, 
and then created a single library by modifying the acid-
binding pocket for further manipulating the stereoselectivity 
toward the acid part of substrate 1a. Residues A281 and A282 
were targeted by site-specific mutagenesis using amino acids 
A(A+), L(L+), and F(F+), respectively. Among the mutants of 
the first generation, A281G was the best mutant in favor of 
(2S, 1’R)-3a with a selectivity of 61% (Fig. 2A). In order to 
reverse enantioselectivity of the acid part, residue Q157, 
which occupies a large space and points to the oxyanion hole, 
was subjected individually to site-specific mutagenesis with 
the introduction of A(A+), L(L+), and F(F+) mutations, 
respectively. To our satisfaction, in this small mutant 
collection, Q157L proved to be the best mutant which 
enhances reversed (R)-selectivity in favor of (2R, 1’R)-3a with 
75% selectivity (Fig. 2B). As a consequence, we decided to 
use A281G and Q157L as the templates for further mutations 
at other chosen sites to improve the stereoselectivity of 
(2S,1’R)-3a and (2R,1’R)-3a, respectively.
In order to improve selectivity in favor of the (2S,1’R)-3a 
enantiomer, the mutants of the second generation were 
generated by mutating A282 to G, L, and F. The screening 
results showed that A281G/A282L is the best mutant among 
this mini-library, improving selectivity from 61% to 66%. 
Further mutation of L+ amino acids at A282 position provided 
a better mutant, A281G/A282V with 71% selectivity in favor 
of (2S,1’R)-3a (Fig. 2A). The same design was applied to the 
third position V190 which gives the third generation FRISM 
mutants. In this generation, the best mutant was found to be 
A281G/A282V/V190C, namely Mutant-SacidRalco, by pathway 
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281→282→190, with excellent selectivity (95/5 d.r; >99/1 e.r) 
(Figs. 2A and 2E). 
In order to improve the selectivity in the formation of 
(Racid,Ralco)-3a, mutant Q157L was used as a template for 
iterative site-specific mutagenesis at other positions. I189 was 
first mutated according to the FRISM strategy. After screening 
this focused mini-library comprising I189A/L/F variants, 
Q157L/I189A (Mutant-RacidRalco) was identified as an excellent 
variant in the formation of (Racid,Ralco)-3a (94/6 d.r; >99/1 e.r) 
(Figs. 2B and 2E).
In the second route, W104 was first replaced by smaller 
amino acids to achieve (S)-selectivity toward the alcohol part 
of the substrate. A previous report had shown that mutation 
W104A induces only moderate (S)-selectivity in the acylation 
of 1-phenylethanol with vinyl butanoate (E = 6.6).21a We 
speculated that in our study W104A is not the only variant that 
could be useful. Therefore, we created a mini-library at 
position 104 containing A, L, and F mutations. To our 
surprise, in the formation of the (2R, 1’S)-3a enantiomer, (R)-
selectivity of the acid part was improved significantly using 
either W104A or W104L. This shows that the modification of 
the alcohol pocket also alters the substrate binding mode in the 
acid pocket, indicating the occurrence of cooperative 
mutational effects.29  The mutant W104A with moderate 
activity was then selected as the template for FRISM-based 
site-specific mutagenesis in order to further enhance (2R, 1’S)-
3a-selectivity (Fig. 2C). It is worth noting that the selectivity 
manipulation in the formation of (2S, 1’S)-3a is much more 
difficult, because both W104A and W104L show very low 
selectivity for this particular absolute configuration (Fig. 2D). 
For improving the selectivity of (2R, 1’S)-3a-formation, we 
therefore used the W104A-template and selected Q157 and 
I189 as the mutation points for the second generation FRISM. 
The choice of these CAST positions was made in view of their 
important effect on (R)-selectivity towards the acid motif of 
the substrate. Surprisingly, most tested mutations at Q157 
including A, L, and F when added to W104A, caused a notable 
reduction of enzyme activity (data not shown), probably due to 
the destruction of the active site in these mutants. In contrast, 
the second generation FRISM mini-library with mutations at 
I189 introduced to the W104A template harbored an excellent 
mutant, W104A/I189V (Mutant-RacidSalco), showing high 
diastereoselectivity (95/5 d.r) and enantioselectivity (>99/1 
e.r) in the formation of (2R, 1’S)-3a (Figs. 2C and 2E). In 
parallel work, the selective preference for (2S, 1’S)-3a was 
first observed with mutant W104A/I189M (35% selectivity, 
Fig. 2D) from the same second generation FRISM mini-library 
as Mutant-RacidSalco. Therefore, the decision was made to 
continue the evolutionary process using this mutant as the 
template to enhance selectivity in the production of (2S, 1’S)-
3a, again by way of FRISM. Initially, this provided mutant 
W104A/I189M/V190C, which showed 50% selectivity for 
(2S, 1’S)-3a. The best mutant was discovered at the end of 
pathway 104→189→190→134. After screening this focused 
mini collection comprising D134A/L/F variants, 
W104A/I189M/V190C/D134L (91/9 d.r; 99/1 e.r) was 
identified as the best mutant for the formation of (2S, 1’S)-3a 
enantiomer (Figs. 2D and 2E).
Substrate Scope of the Evolved CALB Mutants. Next, we 
wanted to see how the four best stereocomplementary mutants 
perform as catalysts in the transesterification of other 
structurally different racemic acids and alcohols. We first 
tested these substrates with WT CALB (Table S3). Most WT 
CALB-catalyzed transesterification reactions provided mainly 
(2R, 1’R)- and (2S, 1’R)-diastereomers with very low d.r. 
values, and no (2R, 1’S)- or (2S, 1’S)-products were detected. 
As before, this is not unexpected, because WT CALB is 
known to display a remarkably high preference for (R)-sec 
alcohols and a relatively low stereoselectivity towards 
substrates with chirality centers in the acid part.21 We also 
tested the performance of the four best stereocomplementary 
mutants in 6 different solvents (Table S4) where WT CALB 
showed different activity and selectivity. Of these solvents, 
isopropyl ether (IPE) was still the best choice for all the four 
best mutants. It is consistent with the result of WT CALB. 
The four best stereocomplementary mutants display quite 
different results with regard to substrate acceptance and 
selectivity (Table 1). By using Mutant-RacidRalco, 
MutantSacidRalco, or MutantRacidSalco, respectively, a number of 
aromatic p-nitrophenol esters and sec-alcohols could be 
efficiently transformed to the corresponding chiral esters with 
remarkably enhanced stereoselectivity. For example, Mutant-
SacidRalco has a broad substrate scope. In the acid domain of the 
target products with (2S, 1’R) configuration, different 
substituents on the phenyl ring, including methyl, halogen, 
isobutyl and different alkyl groups at the α-position such as 
methyl and ethyl are all tolerated. Similarly, in the sec-alcohol 
moiety of the tested substrates, heterocyclic structures and 
various substituents on the phenyl ring are also accepted. 
Remarkably, fatty sec-alcohol structures in the target products 
((2S, 1’R)-3f, (2S, 1’R)-3g) are efficiently differentiated by 
Mutant-SacidRalco, while this cannot be achieved by WT CALB 
because it usually cannot differentiate between methyl and 
ethyl at the α-position of the sec-alcohol fragment of 
substrates.21 Previous reports showed that WT-CALB has very 
low activity and selectivity in the KR of ibuprofen esters such 
as ibuprofen-PNP ester, which has a similar bulky ester group 
as (2S, 1’R)-3r.22b-c Notably, Mutant-SacidRalco also offers a 
very effective resolution for rac-ibuprofen, and high optical 
purity of the (2S, 1’R)-3r product can be obtained. Mutant-
SacidRalco showed excellent stereoselectivity with 99/1 e.r. 
values, and moderate to high distereoselectivity with 
64/36∼97/3 d.r. for all the 18 compounds tested. Interestingly, 
Mutant-SacidRalco also retains good stereoselectivity in the 
conventional KR using substrate rac-1a alone or substrate rac-
2a alone. For example, Mutant-SacidRalco provided the (S)-
product with 21% yield and 99% ee in the transesterification 
of rac-1a and benzyl alcohol. Similarly, it can also provide 
(R)-product with 49% yield and 99% ee in the 
transesterification of rac-2a and vinyl acetate.
Compared with Mutant-SacidRalco, Mutant-RacidRalco has some 
notable differences in substrate scope. Methyl at the α-position 
of the acid section of the target compounds is accepted by 
Mutant-RacidRalco, but not ethyl. Moreover, contrary to Mutant-
SacidRalco, fatty sec-alcohol structures in the targeted products 
((2R, 1’R)-3f and (2R, 1’R)-3g) are not accepted by Mutant-
RacidRalco (Table 1), probably due to the relative large space in 
the alcohol-binding pocket for small alkyl groups. Another 
interesting difference was observed in the formation of (2R, 
1’R)-3j with 1-substituted 
Table 1. Substrate Scope of the Four Best FRISM-derived CALB Mutants as Catalysts in Stereoselective Reactions of rac-
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Esters and rac-Alcohols According to Scheme 1a.
Mutant-SacidRalco
O
O
O
O
O
O
O
O O
O
(2S, 1’R)-3a, 
ton: 1246, yield: 45%,
95/5 d.r., >99/1 e.r.
Emajor >200
(2S, 1’R)-3b, 
ton: 851, yield: 42%,
95/5 d.r.,b >99/1 e.r. c
Emajor >200
(2S, 1’R)-3c, 
ton: 425, yield: 31%,
90/10 d.r., >99/1 e.r.
Emajor >200
(2S, 1’R)-3d, 
ton: 1025, yield: 44%,
92/8 d.r., >99/1 e.r.
Emajor >200
(2S, 1’R)-3e, 
ton:1201, yield: 43%,
83/17 d.r., >99/1 e.r.
Emajor >200
O
O
O
O
O
O
N
O
O N O
O
S
(2S, 2’R)-3f, 
ton: 1025, yield: 47%,
92/8 d.r., >99/1 e.r.
Emajor >200
(2S, 2’R)-3g, 
ton: 1210, yield: 49%,
97/3 d.r., >99/1 e.r.
Emajor >200
(2S, 1’R)-3h, 
ton: 814, yield: 41%,
88/12 d.r., >99/1 e.r.
Emajor >200
(2S, 1’R)-3i, 
ton: 941, yield: 44%,
97/3 d.r., >99/1 e.r.
Emajor >200
(2S, 1’R)-3j, 
ton: 910, yield: 41%,
64/36 d.r., >99/1 e.r.
Emajor >200
O
O
S
O
O
F
O
O
Cl
O
O
Br
O
O
F
(2S, 1’R)-3k, 
ton: 954, yield: 45%,
91/9 d.r., >99/1 e.r.
Emajor >200
(2S, 1’R)-3l, 
ton: 514, yield: 35%,
78/22 d.r., >99/1 e.r.
Emajor >200
(2S, 1’R)-3m,
ton: 1510, yield: 48%,
86/14 d.r., >99/1 e.r.
Emajor >200
(2S, 1’R)-3n, 
ton: 1025, yield: 48%,
89/11 d.r., >99/1 e.r.
Emajor >200
(2S, 1’R)-3o, 
ton: 1014, yield: 47%,
97/3 d.r., >99/1 e.r.
Emajor >200
O
O
Cl
O
O
CF3 O
O
O
O
O
O
(2S, 1’R)-3p, 
ton: 321, yield: 31%,
75/25 d.r., >99/1 e.r.
Emajor >200
(2S, 1’R)-3q, 
ton: 984, yield: 43%,
97/3 d.r., >99/1 e.r.
Emajor >200
(2S, 1’R)-3r, 
ton: 1012, yield: 45%,
92/8 d.r., >99/1 e.r.
Emajor >200
(S)-3v, 
yield: 21%,
99.5/0.5 e.r.
Emajor >200
(R)-3w, 
yield: 49%,
99.5/0.5 e.r.
Emajor >200
Mutant-RacidRalco
O
O
O
O
O
O
O
O O
O
(2R, 1’R)-3a,
ton: 987, yield: 45%,
94/6 d.r., >99/1 e.r. 
Emajor >200
(2R, 1’R)-3b, n.d.d (2R, 1’R)-3c, 
ton: 457, yield: 32%,
89/11 d.r., >99/1 e.r.
Emajor >200
(2R, 1’R)-3d, 
ton: 458, yield: 34%,
92/8 d.r., >99/1 e.r.
Emajor >200
(2R, 1’R)-3e, 
ton: 594, yield: 35%,
86/14 d.r., >99/1 e.r.
Emajor >200
O
O
O
O
O
O
N
O
O
S
O
O
S
(2R, 2’R)-3f, n.d. d (2R, 2’R)-3g, n.d. d (2R, 1’R)-3h, 
ton: 531, yield: 38%,
75/25 d.r., 90/10 e.r.
Emajor 15
(2R, 1’R)-3j, 
ton: 458, yield: 35%,
97/3 d.r., 96/4 e.r.
Emajor 39
(2R, 1’R)-3k, 
ton: 621, yield: 41%,
67/33 d.r., >99/1 e.r.
Emajor >200
O
O
Cl O
O
Br O
O
F
O
O
Cl
O
O
CF3
(2R, 1’R)-3m,
ton: 686, yield: 42%,
97/3 d.r., >99/1 e.r.
(2R, 1’R)-3n, 
ton: 1025, yield: 49%,
88/12 d.r., 94/6 e.r.
(2R, 1’R)-3o, 
ton: 584, yield: 40%,
93/7 d.r., >99/1 e.r.
(2R, 1’R)-3p, 
ton: 451, yield: 35%,
92/8 d.r., >99/1 e.r.
(2R, 1’R)-3q, 
ton: 458, yield: 37%,
95/5 d.r., >99/1 e.r.
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Emajor >200 Emajor 42 Emajor >200 Emajor >200 Emajor >200
Mutant-RacidSalco
O
O
O
O
O
O
O
O
O
O
(2R, 1’S)-3a, 
ton: 968, yield: 43%,
95/5 d.r., >99/1 e.r.
Emajor >200
(2R, 1’S)-3b, 
ton: 476, yield: 31%,
85/15 d.r., b 98/2 e.r.c
Emajor 75
(2R, 1’S)-3c, 
ton: 495, yield: 33%,
83/17 d.r., 97/3 e.r.
Emajor 51
(2R, 1’S)-3d, 
ton: 641, yield: 40%,
93/7 d.r., 98/2 e.r.
Emajor 95
(2R, 1’S)-3s, 
ton: 676, yield: 41%,
86/14 d.r., 96/4 e.r.
Emajor 46
O
O
O
O
10 O
O
F
O
O
Cl
O
O
Br
(2R, 1’S)-3t, 
ton: 632, yield: 37%,
92/8 d.r., 98/2 e.r.
Emajor 87
(2R, 1’S)-3u, n.d. d (2R, 1’S)-3l, 
ton:351, yield: 29%,
80/20 d.r., 80/20 e.r.
Emajor 5
(2R, 1’S)-3m, 
ton: 632, yield: 32%,
94/6 d.r., b 98/2 e.r. c
Emajor 77
(2R, 1’S)-3n, 
ton: 1025, yield: 45%,
88/12 d.r., 96/4 e.r.
Emajor 54
O
O
F
(2R, 1’S)-3o, 
ton: 518, yield: 33%,
80/20 d.r., 97/3 e.r.
Emajor 51
Mutant-SacidSalco
O
O
O
O
O
O
O
O
(2S, 1’S)-3a, 
ton:751, yield: 31%,
91/9 d.r., >99/1 e.r.
Emajor >200
(2S, 1’S)-3b, n.d. d (2S, 1’S)-3c, 
ton: 432, yield: 25%,
71/29 d.r., 96/4 e.r.
Emajor 32
(2S, 1’S)-3d, 
ton: 311, yield: 21%,
78/22 d.r., b 94/6 e.r. c
Emajor 20
a Reaction conditions: 50 mg immobilized lipase (10% enzyme on acrylic resin), rac-1 (50 mM) and rac-2 (45 mM) in 1 ml isopropyl 
ether at 37°C for 12 h. Yields and selectivity were determined by chiral HPLC. bd.r. was determined by NMR. c e.r. was determined by 
combining HPLC data and NMR. d n.d. not detected.
thiophene in the alcohol moiety, and of (2R, 1’R)-3k with 2-
substituted thiophene. Mutant-RacidRalco shows excellent 
distereoselectivity for (2R, 1’R)-3j (97/3 d.r.) and low 
selectivity for (2R, 1’R)-3k, while the result is exactly opposite 
to that of Mutant-SacidRalco. 
Mutant-RacidSalco also shows good substrate scope. A series 
of (2R, 1’S)-esters with various substituents in the acid or 
alcohol moieties can be prepared with moderate to high d.r. 
and e.r. values. Especially, α-alkyl groups with different chain 
length (from methyl to butyl) of the alcohol moiety ((2R, 1’S)-
3d, 3s, 3t) are accepted by Mutant-RacidSalco. However, when α-
alkyl was replaced by dodecyl, no activity was observed, 
implying that the substrate is too large to fit into the pocket. 
Mutant-SacidSalco also increased the target selectivity of several 
substrates. Relatively speaking, the substrate scope of Mutant-
SacidSalco is limited, which may be attributed to the specific 
active site structure of this mutant.
The reactions can be easily scaled up with good activity and 
selectivity, using (2S, 1’R)-3a and (2S, 1’R)-3r as two 
examples. The gram-scale reaction mixture containing 2.25 
mmol 2a and 2.5 mmol rac-1a (or rac-1r) under the catalysis 
of Mutant- SacidRalco provides the corresponding (2S, 1’R)-3a 
with 37% isolated yield (211 mg), 96/4 d.r. and 99/1 e.r., and 
(2S, 1’R)-3r with 40% isolated yield (279 mg), 93/7 d.r. and 
99/1 e.r., respectively. The ester group of the target products 
(e.g., (2S, 1’R)-3r) can be 
 
Table 2. Kinetic Data of WT CALB and Four Different Mutantsa
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Substrate (2R, 1’R)-3a (2R, 1’S)-3a (2S, 1’R)-3a (2S, 1’S)-3a
Mutant Km (mM)
kcat
(s-1)
kcat/Km 
(M-1 s-1)
Km 
(mM)
kcat
 (s-1)
kcat/Km 
(M-1 s-1)
Km 
(mM)
kcat
 (s-1)
kcat/Km 
(M-1 s-1)
Km 
(mM)
kcat
 (s-1)
kcat/Km 
(M-1 s-1)
WT 21.5 9.21 428 - - - 32.2 21.7 674 - - -
Mutant- 
RacidRalco
2.97 2.93 987 - - - 27.3 2.38 87.2 - - -
Mutant- 
SacidRalco
19.7 1.34 68.0 - - - 16.6 15.9 957 - - -
Mutant- 
RacidSalco
14.7 0.040 2.72 3.80 0.59 155 9.87 0.003 0.31 14.9 0.018 1.21
Mutant- 
SacidSalco
12.0 0.006 0.51 17.1 0.046 2.69 22.5 0.005 0.22 3.89 1.32 339
a Reaction conditions: 5mg immobilized lipase, rac-1a (3-40 mM) and rac-2a (100 mM) in 1 ml isopropyl ether at 37°C. Samples 
were taken at different reaction intervals for HPLC analysis.
Figure 3. (A) Cartoon representation of the overall crystal structures of WT (PDB Code 5A7130, gray), Mutant- RacidRalco (PDB 
Code 6J1R, red), Mutant- RacidSalco (PDB Code 6J1Q, orange), Mutant- SacidRalco (PDB Code 6J1P, cyan), and Mutant- SacidSalco 
(PDB Code 6J1S, blue). Images B-E represent the surface of the binding pocket of these mutants (B: Mutant- RacidRalco; C: Mutant- 
SacidRalco; D: Mutant- RacidSalco; E: Mutant- SacidSalco). In images B-E, some representative residues are represented by sticks with 
different colors. S105 and H224 in B-E are colored in black and gray, respectively. All mutations in these four mutants are 
underlined. 
easily hydrolyzed by using well-established methods, to give 
optical pure acids and alcohols simultaneously. This result 
also documents the synthetic utility of stereodivergent 
mutants of CALB in transesterification reactions.
These stereocomplementary mutants have largely retained 
thermostability relative to WT CALB. The measured T50 
value of WT CALB (58.6 °C) and those of the four Mutants 
RacidRalco (55.7 °C), SacidRalco (59.2 °C), RacidSalco (53.6 °C) 
and SacidSalco (51.3 °C) suggest that the evolved mutations 
responsible for manipulated stereoselectivity do not impair 
the thermostability of the enzyme to any significant degree.
Deconvolution Experiments. In order to explore the 
effect of each amino acid exchange in the four best variants 
on the specific selectivity for the transesterification of 2-
phenyl propionic acid p-nitrophenyl ester (1a) and 1-
phenylethanol (2a), partial deconvolution of the four best 
variants was performed. This was achieved by applying site-
directed mutagenesis on WT CALB with creation of a select 
series of variants (Table S5).
For Mutant-SacidRalco, three single mutations and the double 
mutations derived from their combination proved to be 
ineffective in improving the (2S, 1’R)-selectivity relative to 
WT, while the triple mutant (V190C/A281G/A282V) was 
found to display 95% selectivity toward (2S, 1’R)-
enantiomer, showing a remarkable synergistic effect29 (Table 
S5, entries 1-7). Similar cooperative effects were also found 
in Mutant-SacidSalco, where all deconvoluted mutants showed 
low or even no preference for the (2S, 1’S)-enantiomer, 
while in concert their assembly showed 91% selectivity for 
the target enantiomer (Table S5, entries 14-27). It is also 
worth noting that in Mutant-RacidSalco, the mutation of 
W104A in the alcohol-binding pocket resulted in a 
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significant improvement of (2R, 1’S)-selectivity (Table S5, 
entry 11), completely reversing the (2S, 1’R)-preference of 
WT CALB. This result speaks for “remote” mutational 
effects. 
Kinetic Studies. Kinetic parameters were measured for 
WT-CALB and the four stereocomplementary mutants 
(Table 2). It is noteworthy that WT-CALB has similar 
activity (kcat/Km) towards the stereoisomers of (2R, 1’R)-3a 
and (2S, 1’R)-3a, whereas very low activity was determined 
in the case of (2R, 1’S)-3a and (2S, 1’S)-3a. The high 
preference of WT-CALB for the (R)-sec alcohols moiety 
probably plays a role. For the stereodivergent mutants, 
distinct trends were observed. For example, compared to WT 
CALB, the kcat/Km of Mutant-RacidSalco for (2R, 1’R)-3a and 
(2S, 1’R)-3a decreased from 428 and 674 to 2.7 and 0.3 M-1s-
1, respectively, while the kcat/Km for (2R, 1’S)-3a increased 
from essentially 0 to 155 M-1s-1. Similarly, Mutant-SacidSalco 
displays high kcat/Km (339M-1s-1) for (2S, 1’R)-3a, while it 
hardly transforms other enantiomers. In the case of Mutant-
RacidRalco and SacidRalco, the preference of the respective (2R, 
1’R)- and (2S, 1’R)-enantiomers is also clearly indicated by 
the correspondingly increased kcat/Km (Table 2). 
Crystallography. To better understand the relationship 
between the manipulated stereoselectivities and specific 
protein structures, we obtained X-ray crystal structures of the 
four best mutants at 1.60∼1.83-Å resolution (Table S7). 
Each mutant contains two chains in one asymmetric unit, and 
the two monomers have almost the same structure of the 
protein scaffold, except for loop 140-147, which displays 
open and closed conformations, respectively (Fig. 3 and Fig. 
S1). Different from that found by Stauch et al. (PDB: 
5A71),30 our closed conformation is similar to the structure 
reported by Uppenberg et al. (PDB: 1TCA).20b In the open 
chain conformation, the flexible loop 140-147 is located 
away from the entrance of the reaction chamber relative to 
WT CALB, thereby exposing the active site. Our B-factor 
analysis31 of loop 140-147 in all four mutants indicates 
higher flexibility relative to that in CALB-WT (PDB: 
1TCA).20b The structural promiscuity of the variants around 
the substrate entrance may account for their lower Km values 
compared to that of WT, especially toward the preferred 
stereoisomers. Remarkably, the four stereodivergent variants 
display significantly different structures of the respective 
active sites (Fig. 3B-E). Variants with the same selectivity 
toward the acid moiety show a similar shape of the acid 
pocket, for example Mutant-RacidRalco vs. Mutant-RacidSalco, or 
Mutant-SacidRalco vs. Mutant-SacidSalco. The (R)-acid selectivity 
pockets of Mutant-RacidRalco and RacidSalco have the same 
V190 residue and relatively small 189 residue (A and V), 
while the (S)-acid selectivity pockets of Mutant-SacidRalco and 
SacidSalco have the same C190 residue and a relatively large 
189 residue (I and M). Similarly, (R)-alcohol--selective 
Mutants-RacidRalco and SacidRalco have a small space of the 
alcohol-binding pockets due to large W104 position, while 
Mutants-RacidSalco and SacidSalco have large and deep alcohol-
binding pockets with a preference for (S)-alcohols. 
Further, we attempted to get a complex structure which 
shows how the substrates or products dock in the reaction 
pocket. Since 3a and 1a are easily hydrolyzed by CALB 
mutants under most crystallization conditions, 1-
phenethylamine 2-phenyl propionic (3a’) was used as an 
analog. Unfortunately, only one complex of Mutant-SacidRalco 
with (2S, 1’R)-3a’ at the reaction site crystallized for X-ray 
analysis (Fig. S2). As in the case of the apo-protein, two 
monomers make up an asymmetric unit in the complexed 
structure. Substrate (2S, 1’R)-3a’ was found to be located 
slightly next to the catalytic site of the open monomer, with 
an occupancy of 91%. As expected, the methyl-group of the 
alcohol moiety points to the alcohol-binding pocket, 
surrounded by W104, while the phenyl is kept out of the 
entrance. Unfortunately, it was not possible to identify the 
exact binding mode of the acid part.
Unveiling the Source of Differing Stereoselectivity of 
CALB Variants. To obtain some insight regarding the 
source of differing stereoselectivity of the four highly 
stereocomplementary CALB variants, four enantiomeric 
ligands of 3a were docked into the binding pockets of 
variants RacidRalco, SacidRalco, RacidSalco and SacidSalco, 
respectively, and 100-ns molecular dynamic (MD) 
simulations were conducted. For the MD simulated structure, 
we measured in particular the distance between the S105 
oxygen of the catalytic triad and the carbonyl carbon of the 
ester substrate (Fig. S3). In all four cases, the shortest 
distance proved to be the one that leads to the observed 
stereoselectivity. The binding enthalpies of the four ester 
enantiomers in the variants were calculated using the 
MM/GBSA method.32 It can be seen that the order of binding 
enthalpies correlates with the respective stereoselectivities: 
The stronger, the more selective (Table S8). Since the 
entropy changes would be similar when the four different 
stereoisomeric ligands bind with a same variant, only the 
enthalpies were computed and the entropy contributions 
were neglected in these calculations (Eq. 2 in supporting 
information).
The MD results also show that the binding modes of the 
four stereoisomers in their respective stereoselective variants 
are divergent. From the MD structure comparison between 
the complex of Mutant-RacidRalco (I189A/Q157L) and (2R, 
1’R)-3a, and the complex of Mutant-SacidRalco 
(V190C/A281G/A282V) and (2S, 1’R)-3a (Fig. 4A, C & D), 
it was found that the binding modes of the two enantiomers 
in their corresponding optimal mutants are completely 
different, which are relevant to their different 
enantioselectivity. In the Mutant-RacidRalco complex, the 
methyl substituent of the acid moiety of (2R, 1’R)-3a points 
to L157 position, while the hydrogen atom pointing to I189 
at the loop 184-194 (Fig. 4A, D). In Mutant-SacidRalco, the 
orientation of methyl and hydrogen of (2S, 1’R)-3a is 
reversed (Fig. 4A, C). The benzene group of the acid moiety 
in both enantiomers have the similar orientation, pointing to 
the entrance of the acid pocket. Moreover, the whole pocket 
of Mutant-SacidRalco for binding alcohol and acid is more 
closed than that of Mutant-RacidRalco (I189A/Q157L) (Fig. 
4A), due to the different movement of 
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 Figure 4. MD-simulated binding modes of various enantiomers in their respective selective CALB variants. (A) Cartoon 
representation comparison of (2S, 1’R)-3a enantiomer bound in Mutant-SacidRalco (green) and (2R, 1’R)-3a enantiomer in Mutant-
RacidRalco (purple). (B) Cartoon representation comparison of (2R, 1’R)-3a enantiomer in Mutant-RacidRalco (purple) and (2R, 1’S)-
3a enantiomer in Mutant-RacidSalco (yellow). C-E images are the enlarged binding modes of (2S, 1’R)-3a enantiomer in Mutant-
SacidRalco (C), (2R, 1’R)-3a enantiomer in Mutant-RacidRalco (D) and (2R, 1’S)-3a enantiomer in Mutant-RacidSalco (E). (F) Structure 
comparison of the lid 140-149 of four different mutants. (G) The surface of the binding pocket of four different mutants binding 
with their respective enantiomers. In images C-E, the mutated residues are represented by orange sphere, and other representative 
resides are represented by sphere or sticks with different color. The catalytic triad (S105-H224-D187) in C-E are colored in light 
blue. In image G, the mutated residues are represented by orange surface.
 
the lid 140-149 and the helix 265-285 caused by 
corresponding mutations. 
In the case of (2R, 1’R)-3a binding in the Mutant-RacidRalco 
(I189A/Q157L), the ligand is exposed to three IPE solvent 
molecules (Fig. 4D). Compared the apo variant, the binding of 
the ligand pushes the 265-285 helix away from the active site 
and I285 moves closer to the benzene group of the acid moiety 
(Fig. S6B). Accordingly, L278 moves away from the alcohol 
moiety and L277 becomes fully exposed pointing outward the 
binding site. As a result, a large entrance to the alcohol pocket 
is formed to accommodate the benzene-moiety of the alcohol 
moiety (Fig. 4D, 4G and S6B) and the methyl group of the 
alcohol portion forms favorable hydrophobic interaction with 
W104, which accounts for the high selectivity toward the (R)-
secondary alcohol part. The phenyl group of the alcohol 
moiety is nested in a hydrophobic domain formed by H224, 
L278, A282 and I285 (Fig. 4D). On the other hand, with the 
ligand bound, the lid region exhibits a more open 
conformation compared to the Mutant-SacidRalco complex. The 
incorporation of medium size leucine at position 157 provides 
suitable space and hydrophobic interaction with the methyl of 
the acid moiety, such that smaller or larger mutations caused 
the decrease of target selectivity (Fig.2B). The pointing of 
methyl to L157 pushes the ligand closer the helix 265-285. 
Meanwhile, the mutation of I189A provides a relative large 
space to accommodate the chiral center containing a large 
benzene group of the acid moiety. The benzene of the acid 
moiety forms hydrophobic interactions with V154, L157, I285 
and A189 (Figs. 4D). 
With the ligand (2S, 1’R)-3a binding, the phenyl group of 
the alcohol moiety establishes favorable hydrophobic 
interactions with H224, L278 and V282 in Mutant-SacidRalco 
(V190C/A281G/A282V) (Fig. 4C, S5A and S6A). The 
conformational change around the helix 265-285 induced by 
A282V/A281G mutations results in a closed alcohol pocket 
(Fig. 4A, 4C and 4G). The methyl group of the alcohol portion 
forms favorable hydrophobic interaction with W104 and 
thereby accounts for the high selectivity toward the (R)-
secondary alcohol part. On the other hand, the V190C 
mutation causes the conformational change of the loop where 
it is located. As a result, the acid-selective pocket of CALB is 
reshaped and the orientation of methyl and hydrogen of (2S, 
1’R)-3a is reversed compared with the complex of Mutant-
RacidRalco accounting for the (S)-selectivity of the acid pocket. 
The benzene of acid moiety forms hydrophobic interactions 
with I189, as well as T138, Q157 and V154.
Similar differences between the orientation of the acid 
moiety in (2R, 1’S)-3a and (2S, 1’S)-3a enantiomers in their 
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optimal mutants are also observed (Fig. S4B and 4G). 
Interestingly, two mutants with the same acid-selectivity show 
the similar conformation of the lid 140-149 (Fig. 4F). 
Additionally, the MD structure comparison between the 
complex of Mutant-RacidRalco (I189A/Q157L) and (2R, 1’R)-3a, 
and the complex of Mutant-RacidSalco (W104A/I189V) and (2R, 
1’S)-3a (Fig 4B) offers insight about the source of different 
sec-alcohol stereoselectivity of CALB variants. It was found 
that both the conformation of the acid pockets of the two 
mutants and the orientation of their ligands are very similar, 
implying their similar acid-selectivity. The reversion of 
alcohol selectivity was mainly caused by the W104A mutation, 
which creates extra space for the accommodation of large-
sized benzene group in the alcohol moiety of ligands, and 
therefore accounts for the reversed (S)-alcohol-selectivity for 
(2R, 1’S)-3a in Mutant-RacidSalco (W104A/I189V) (Fig. 4E and 
4G). W104A mutation not only changes the alcohol 
selectivity, but also influences the binding mode of the acid 
moiety of the ligand. The whole ligand moves closer to the 
helix 265-285, due to the sliding of the benzene of the alcohol 
moiety into the alcohol-binding pocket (Fig. 4B and 4E). This 
movement provides extra space for the methyl substituent 
pointing to Q157, accounting for the astonishing increase of 
(R)-acid selectivity from essentially 0 (WT) to 81% (W104A) 
(Fig. 2C). Moreover the mutation of I189V further improves 
this selectivity, similar to that in the case of Mutant-
RacidRalco(Fig. 4G and 2C). 
Conclusions and Perspectives. In summary, by way of a 
highly focused protein engineering method dubbed “focused 
rational iterative site-specific mutagenesis” (FRISM), we have 
addressed the challenging issue of stereodivergent engineering 
of Candida antarctica lipase (CALB) with generation of four 
highly stereocomplementary variants needed to access 
catalytically all four stereoisomers bearing two stereocenters 
in transesterification reactions between racemic acids and 
racemic alcohols in an organic solvent. Although non-aqueous 
reaction conditions are known to be challenging in directed 
enzyme evolution,16,24a our FRISM strategy required the 
generation and screening of less than a total of 100 
transformants in the quest to achieve >90% selectivity for all 
of the four possible stereoisomers in the model reaction. This 
was accomplished by first applying exploratory site-directed 
mutagenesis at 7 selected sites lining the binding pocket of 
CALB using only 3 representative amino acids, including 
alanine (A), leucine (L), and phenylalanine (F). Following the 
identification of key mutations at the identified hotspots, 
further site-specific mutagenesis was performed iteratively 
using similar-sized amino acids (A+: G; L+: V/C/I/M; F+: 
Y/W). Saturation mutagenesis with formation of traditional 
libraries was not needed.
In most previous protein engineering studies of CALB or 
other lipases, the respective binding pocket was “divided” into 
two parts, the acid (acyl) and the alcohol binding domains.21,22 
Mutations were then restricted to the chirality-containing 
domain, defined by the nature of the substrate. In the present 
study, however, we discovered that mutations in one domain 
influence the stereoselectivity of the other, a result of “remote” 
effects.
The experimental results concerning complete control of 
both absolute and relative configuration in compounds having 
two stereogenic centers, catalyzed by CALB mutants, are of 
synthetic significance because they provide access to all 
possible stereoisomers, as in the case of the therapeutic drug 
candidates of the ibuprofen-type (Table 1). Moreover, both 
chiral alcohols and acids are extensively used in 
pharmaceutical industry, and the four stereodivergent 
enantiomers can be hydrolyzed to obtain optical pure acids 
and alcohols, simultaneously. The best stereocomplementary 
mutants display relatively broad substrate scopes, except for 
Mutant-SacidSalco. Importantly, a significant tradeoff in 
thermostability was not observed in the evolved variants. 
Consequently, the range of CALB applications has been 
expanded considerably. In order to gain structural insight into 
the source of stereodivergent selectivity of the four best 
mutants, crystals were grown and studied by X-ray analysis, 
flanked by docking studies and molecular dynamics (MD) 
simulations. 
Finally, we point out that the FRISM method of protein 
engineering constitutes a logical fusion of rational design21,24,33 
and directed evolution.14,16 The decisions concerning the 
choice of the amino acids in the site-specific mutagenesis 
steps can be supported by X-ray structural and consensus data 
as well as computational aids such as machine learning34 or 
Rosetta design.33d We expect that in the future, FRISM will be 
used in the protein engineering studies of other enzymes for 
enhancing stereo- and regioselectivity as well as activity 
and/or thermostability. 
MATERIALS AND METHODS
Library Generation. The PCR (50 μL final volume) 
contained: ddH2O (29 μL), Pfu 10X buffer (5 μL), dNTP (4 
μL, 2.5 mM each), forward primers (5 μL, 2.5 μM each), silent 
reverse primer 
(GATGCCGGGAGCAGACAAGCCCGTCAGGGCGC, 5μL, 
2.5 μM), template plasmid (pETM11-CALB, 1.0 μL, 100 
ng/μL) and 1 μL of Pfu polymerase. PCR conditions used 
were 94 °C, 5 min; 30 cycles of (94 °C, 1 min; 60 °C, 1 min; 
72 °C, 14 min) and final extension at 72 °C, 10 min. Then, the 
PCR mixtures were mixed with 2 μL DpnI (10 U/μL) and 
incubated overnight at 37 oC. The product was purified with an 
Omega PCR purification spin column, and an aliquot of 15 μL 
was used to transform 80 μL of electrocompetent E. coli BL21 
(DE3) cells, which contain chaperone plasmid pGro7 (Takara, 
Japan). The transformation mixture was incubated with 1 mL 
of LB medium at 37 °C under shaking of 200 rpm for 1 hour 
and spread on LB-agar plates containing Kanamycin (34 mg/L) and Chloramphenicol (34 mg/L), and the plates were 
incubated for 16-24 hours. A single colony was picked and 
incubated in 5 mL of LB medium at 37 °C overnight. The 
plasmid was extracted with an Omega gel extraction column, 
and sequenced by Sangon Biotech (Shanghai, China). Target 
mutants were stored with glycerol at -80 °C.
Scaffold Expression. 100 μL stored bacteria were first 
inoculated in 5ml LB medium (containing 34 μg/mL 
Kanamycin and 34 μg/mL Chloramphenicol), and shaken 
overnight as preculture. A fresh 1L of TB medium with 1.0 
mg/mL L-arabinose as the inducer for expression of chaperone 
pGro7 and the same concentration antibiotics as above, was 
inoculated from 5 mL preculture. The cultures were allowed to 
grow at 37 °C until OD (600) at 0.6～0.8. After cooling at 4°C 
for 1h, 1.0 mM isopropyl β-thiogalactopyranoside (IPTG) was 
added to induce CALB expression. The cultures were allowed 
to express at 16 °C for 48h with shaking at 200 rpm. Then 
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cells were harvested by centrifugation at 9000 rpm and 4 oC 
for 10 min and the supernatants were discarded. The cells 
were resuspended in 20mL 50 mM phosphate buffer (pH 7.4) 
and stored at -80°C.
Purification and Immobilization of CALB Mutants. The 
cells were subjected to repeated freezing and thawing for 3 
times, and then the target proteins were released by sonication. 
The cell debris was removed by centrifugation at 12,000 rpm 
for 15 min at 4.0 °C. The supernatant was filtered and loaded 
on a GE Healthcare HisTrap FF Crude column (5 mL) 
preequilibrated with 50 mM phosphate buffer (pH 7.4) 
containing 0.5 M NaCl and 5 mM imidazol. Impurity and 
chaperone were removed by imidazol at the concentration of 
about 70 mM and the enzyme was eluted by 50 mM Tris-HCl 
buffer with 0.5 M NaCl and 200 mM imidazol. The proteins 
were dialyzed by 50 mM phosphate buffer (pH 7.4) for one 
day at 4°C. Then, the purified enzyme solution was mixed 
with acrylic resin in 50 mL EP tube and stirred end-over-end 
rotation at 20 °C, overnight. Then, the resin was filtered and 
freeze-dried in vacuo. The immobilized lipase was used for the 
kinetic resolution in organic phase.
General Procedure for Kinetic Resolution of Substrates. 
50 mg immobilized CALB (10% enzyme on acrylic resin) was 
added to 1 mL anhydrous IPE containing substrates rac-1a 
(50mM) and rac-2a (45mM), and this mixture was shaken at 
200 rpm and 37 °C for about 12 h. The reaction mixture was 
filtered and evaporated in vacuo. Conversion and selectivity 
were determined by chiral HPLC using specific conditions as 
shown in the section of HPLC chromatograms. The crude 
products were purified by silica gel chromatography 
(petroleum ether and ethyl acetate).
Scale-up of Kinetic Resolution of Substrate (2S, 1’R)-3a 
and (2S, 1’R)-3r. 150 mg immobilized CALB (10% enzyme 
on acrylic resin) was added to 5 mL anhydrous IPE containing 
1a (or 1r) (500mM) and 2a (450mM), and this mixture was 
shaken at 200 rpm and 37 °C for about 48h. The process was 
monitored by chiral HPLC. The mixture was filtered and 
evaporated under reduced pressure, and purified by column 
chromatography to provide the corresponding (2S, 1’R)-3a 
with 37% isolated yield (211 mg), 96/4 d.r. and 99/1 e.r., and 
(2S, 1’R)-3r with 40% isolated yield (279 mg), 93/7 d.r. and 
99/1 e.r., respectively. 
X-ray Structure Determination. Four best variants, 
Mutant-RacidRalco, Mutant-SacidRalco, Mutant-SacidSalco, Mutant-
RacidSalco and Mutant-SacidRalco in complex with 3a’ were 
crystalized by using the sitting-drop vapor diffusion method at 
18 °C. All crystals were mounted in nylon loops and flash-
frozen in liquid nitrogen. All diffraction data was collected at 
the wavelength of 0.97775 Å on SSRF beamline 19U1 of the 
National Center for Protein Science Shanghai (China). All 
data collection was performed at 100 K. All data sets were 
indexed, integrated, and scaled using the HKL2000 package.35 
The apo-mutant structures were solved by molecular 
replacement method using the program PHASER,36 and the 
structure of WT-CALB (PDB code 1TCA) as a search model. 
The complex structure was solved by the same method using 
the structure of Mutant-SacidRalco as a search model. Rounds of 
automated refinement were performed with PHENIX,37 and 
the models were extended and rebuilt manually with COOT.38 
The statistics for data collection and crystallographic 
refinement are summarized in supporting information. The 
atomic coordinates of four best variants Mutant-RacidRalco 
(PDB Code 6J1R), Mutant-RacidSalco (PDB Code 6J1Q), 
Mutant- SacidRalco (PDB Code 6J1P), and Mutant-SacidSalco 
(PDB Code 6J1S), and Mutant-SacidRalco in complex with 3a’ 
(PDB Code 6J1T) have been deposited in the Protein Data 
Bank (PDB). 
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